OpportunityTitle: CDER Strategic Communication Outreach
AdditionalInformationOnEligibility: CDER recognizes and endorses the need for full and open competition, and by preference utilizes open competition in the vast majority of its initiatives. For the CDER Strategic Communication Outreach funding opportunity announcement, CDER seeks creative communications approaches to many of the significant public health problems it has identified. Historically non-profits have developed the membership and broad audience outreach, including the elderly, children, healthcare professionals and young adults, that CDER is seeking.  Such public/private partnerships make tremendous strides in changing or re-enforcing public beliefs about the risks and benefits, safe use, and sound practices of medical products, especially human drugs.
Description: Reaching out to inform the American people is part of the mission of FDA&#146;s Center for Drug Evaluation and Research (CDER) to promote and protect the public health. Communication about the risk and benefits, safety and effectiveness of human drug products to the public can be complex and challenging. As such, CDER&#146;s Office of Communications (OCOMM) wants to leverage its communication efforts and collaborate with public outreach groups about its key initiatives and issues. To effectively communicate with the public, CDER often tailors its messages to targeted segments of the population, i.e., elderly, children, healthcare professionals and young adults. Utilizing multiple approaches to convey information to the public may include multi-pronged educational campaigns, social media, the website, and working with various stakeholder groups. CDER/OCOMM is soliciting proposals on a competitive basis for innovative projects that will foster better understanding of the work of CDER and the impact of that work on public health. CDER seeks to work with a non-profit educational public health outreach group with a commitment to educate and inform the American people about their medicines and the steps they can take to ensure proper use of those medicines.
GrantorContactEmailDescription: FDA e-mail
GrantorContactText: Gladys Melendez Bohler &lt;br/&gt;Grants Management Specialist/Officer &lt;br/&gt;Phone 301-827-7168